06/12/2014 - 2:00pm

Valeant Pharmaceuticals International announced that its subsidiary, Valeant Pharmaceuticals North America, received approval from the Food and Drug Administration for its new drug application for Jublia (efinaconazole 10% topical solution). The drug is the first topical triazole approved for the treatment of onychomycosis of the toenails, the company said.

06/12/2014 - 11:43am

The House Energy and Commerce Committee on Tuesday advanced bipartisan legislation sponsored by full committee vice chair Marsha Blackburn to address the nation’s growing prescription drug abuse epidemic.

06/11/2014 - 12:58pm

More than 29 million people in the United States have diabetes, up from the previous estimate of 26 million in 2010, according to a report released Tuesday by the Centers for Disease Control and Prevention.

06/11/2014 - 12:52pm

Strativa Pharmaceutical, a division of Par Pharmaceutical Cos., announced that the Food and Drug Administration approved Nascobal, a prescription B-12 supplement administered once a week as one spray.

06/11/2014 - 10:45am

QS/1, a complete healthcare automation solutions provider, on Tuesday announced it is partnering with VUCA Health to offer on-demand prescription-specific videos, as well as other services to engage patients and strengthen customer relationships.

06/10/2014 - 2:03pm

New York Gov. Andrew Cuomo last week announced an agreement between New York State and GW Pharmaceuticals to develop clinical trials using an active ingredient derived from the marijuana plant to help treat children diagnosed with epilepsy who suffer from seizures and other medical complications.

06/10/2014 - 1:42pm

As many as 40% of U.S. narcotic prescriptions in 2011-2012 were written by only 5% of opioid prescribers, according to a study Express Scripts presented Monday at AcademyHealth's annual research meeting.

06/09/2014 - 12:45pm

BioDelivery Sciences International on Monday announced that the Food and Drug Administration approved its new drug application for Bunavail (buprenorphine and naloxone) buccal film (CIII).

06/09/2014 - 12:35pm

Bayer last week named Dieter Weinand president of Bayer HealthCare Pharmaceuticals effective Aug. 1.